AstraZeneca technical support at 7121

Blue avatar for FOREX.com guest contributors
By :  
December 14, 2020 4:33 AM
5 views
Graphic of trading data chart
Blue avatar for FOREX.com guest contributors
By :  
AstraZeneca, the global biopharmaceutical firm, announced its acquisition of rare-disease US specialist Alexion Pharmaceuticals for $39 billion or $175 per share. Alexion shareholders will receive $60 in cash and 2.12 of AstraZeneca's shares for each share they hold. The transaction values Alexion at $175 per share, 45% above its closing price on Friday on Wall Street. This is the largest acquisition in the pharmaceutical sector since the beginning of the pandemic.

Separately, the Company reported that its Trixeo Aerosphere has been approved in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD).

From a chartist point of view, the stock price is under pressure within a bearish channel and is nearing its lower Bollinger boundary. The daily RSI (14) lacks downward momentum. Prices remain supported by the rising 100WMA currently at 7350. As long as 7121 is support, a rebound could take place.  A push above 8140 would open a path to see 8848. Alternatively, a break below 7121 would call for a bearish acceleration towards 6315 and 5871.

Market chart demonstrating AstraZeneca Technical Support At 7121. Published in December 2020 by FOREX.com

Source: TradingView, Gain Capital

 

Related tags: Equities UK

Latest market news

Russell 2000 leads markets higher, despite another strong jobs report
Yesterday 06:19 PM
Nasdaq 100 analysis: Goldilocks NFP takes NDX to 14-month highs
Yesterday 05:29 PM
Earnings This Week: Wizz Air, GameStop and NIO
Yesterday 01:53 PM
Reddit stocks: what meme stocks are trending?
Yesterday 12:00 PM
EUR/USD, AUD/USD and USD/CAD forecast – Forex Friday
Yesterday 10:00 AM
FTSE 100 analysis: Up on US debt ceiling vote as Dechra backs takeover
Yesterday 07:10 AM

Open an account in minutes

Experience award-winning platforms with fast and secure execution.

Open account

Web Trader platform

Our sophisticated web-based platform is packed with features.
Learn more

Economic Calendar

view more

Latest Equities articles

An office of traders with multiple trading screens
Earnings This Week: Wizz Air, GameStop and NIO
By:
Joshua Warner
Yesterday 01:53 PM
    Close-up of stock market board
    Reddit stocks: what meme stocks are trending?
    By:
    Joshua Warner
    Yesterday 12:00 PM
      Research
      FTSE 100 analysis: Up on US debt ceiling vote as Dechra backs takeover
      By:
      Joshua Warner
      Yesterday 07:10 AM
        Research
        FTSE 100 Analysis: British Land loses blue-chip status after 20 years
        By:
        Joshua Warner
        June 1, 2023 07:10 AM

          StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.

          StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.